J Natl Cancer Inst:超重和肥胖女性乳腺癌生存者患第二原发肿瘤的风险明显升高

2021-12-22 yd2015 MedSci原创

研究表明,超重和肥胖女性乳腺癌生存者患第二原发肿瘤的风险明显升高

与普通人群相比,乳腺癌幸存者罹患第二原发肿瘤的风险更高。人们对身体质量指数(BMI)是否会增加这种风险知之甚少。因此,有来自美国的团队开展了相关研究,评估BMI和侵袭性乳腺癌患者发生第二原发肿瘤的关系。相关研究成果发表在Journal of the National Cancer Institute(JNCI)杂志上。

该回顾性队列包括来自Kaiser Permanente Colorado和Washington的6481例患者,其中822例(12.7%)发生了第二原发肿瘤(平均随访时间为88.0个月)。BMI从诊断第一肿瘤时的医疗记录中提取出来。结果包括:1)所有第二原发肿瘤,2)肥胖相关第二原发肿瘤,3)任何乳腺第二原发肿瘤,4)雌激素受体阳性的乳腺第二原发肿瘤。多变量第二原发肿瘤回归模型用于评估BMI和第二原发肿瘤的相对风险(RRs)和95%置信区间(CI),对部位、诊断年份、治疗、人口统计和肿瘤特征等进行调整后。

首次诊断乳腺癌的平均年龄为61.2岁(11.8岁),大多数患者在最初诊断时超重(33.4%)或肥胖(33.8%)。大多数病例诊断为I期(62.0%),ER阳性(80.0%)或PR阳性(69.3%),但肥胖女性诊断为II期或III期的比例略高于BMI正常女性。

在平均88.0个月(12-322个月)的随访中,822名女性(12.7%)再次诊断出癌症;其中,508例(61.8%)与肥胖有关,333例(40.5%)与乳腺癌有关。大多数第二乳腺癌(231,69.4%)是ER阳性乳腺癌。508例肥胖相关癌症包括283例绝经后乳腺癌、70例结直肠癌、68例子宫癌、21例卵巢癌、23例胰腺癌、14例肾脏癌,以及不足10例甲状腺癌、多发性骨髓瘤、脑膜瘤、肝脏癌、贲门癌、胆囊癌和食道癌。

               第二原发肿瘤发病情况

总的来说,BMI的增加与患第二种癌症的风险增加有关。BMI每增加5kg/m2,任何第二原发肿瘤的发病风险提高7% (RR ¼ 1.07, 95% CI ¼ 1.01 to 1.14); 肥胖相关肿瘤风险提高13% (RR ¼ 1.13, 95% CI ¼ 1.05 to 1.21);第二原发乳腺癌风险提高11% (RR ¼ 1.11, 95% CI ¼ 1.02 to 1.21); 第二原发ER阳性乳腺癌风险提高15% (RR ¼ 1.15, 95% CI ¼ 1.04 to 1.27)。

              第二原发肿瘤发病风险比

对于所有第二种肿瘤,BMI小于25.0kg/ m2的女性与BMI大于或等于25.0kg/ m2的女性相比,经多变量调整的相对风险为1.09 (95% CI 0.94 - 1.26);因此,超重和肥胖的可归因分数为7.9。

综上,研究表明,超重和肥胖女性乳腺癌生存者患第二原发肿瘤的风险明显升高。

原始出处:

Feigelson HS, Bodelon C, Powers JD, Curtis RE, Buist DSM, Veiga LHS, Bowles EJA, Berrington de Gonzalez A, Gierach GL. Body Mass Index and Risk of Second Cancer Among Women With Breast Cancer. J Natl Cancer Inst. 2021 Sep 4;113(9):1156-1160. doi: 10.1093/jnci/djab053. PMID: 33823007.

版权声明:
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于williamhill asia 医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章,或“williamhill asia 号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系,williamhill asia 将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1977612, encodeId=25c419e7612aa, content=<a href='/topic/show?id=d9e5130962f' target=_blank style='color:#2F92EE;'>#NST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13096, encryptionId=d9e5130962f, topicName=NST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c5136, createdName=drj2003, createdTime=Mon Nov 07 11:08:59 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1776494, encodeId=da031e76494d1, content=<a href='/topic/show?id=6f553e14927' target=_blank style='color:#2F92EE;'>#原发肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37149, encryptionId=6f553e14927, topicName=原发肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09b838947217, createdName=经常头晕, createdTime=Thu Sep 15 01:08:59 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1885559, encodeId=751d18855598d, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sun May 22 16:08:59 CST 2022, time=2022-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950259, encodeId=d4a9195025971, content=<a href='/topic/show?id=f3b329482a' target=_blank style='color:#2F92EE;'>#ATL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2948, encryptionId=f3b329482a, topicName=ATL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09892, createdName=qidongfanjian, createdTime=Sat Oct 15 14:08:59 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1987876, encodeId=9b4b198e876ae, content=<a href='/topic/show?id=7fa58190354' target=_blank style='color:#2F92EE;'>#肥胖女性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81903, encryptionId=7fa58190354, topicName=肥胖女性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fca128, createdName=licz0423, createdTime=Sun Sep 11 06:08:59 CST 2022, time=2022-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083512, encodeId=9e6f1083512e2, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e0f5588916, createdName=ms4000001117609205, createdTime=Thu Dec 23 11:17:48 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083224, encodeId=5cff108322404, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e495565045, createdName=王江军, createdTime=Wed Dec 22 21:25:25 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2022-11-07 drj2003
  2. [GetPortalCommentsPageByObjectIdResponse(id=1977612, encodeId=25c419e7612aa, content=<a href='/topic/show?id=d9e5130962f' target=_blank style='color:#2F92EE;'>#NST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13096, encryptionId=d9e5130962f, topicName=NST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c5136, createdName=drj2003, createdTime=Mon Nov 07 11:08:59 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1776494, encodeId=da031e76494d1, content=<a href='/topic/show?id=6f553e14927' target=_blank style='color:#2F92EE;'>#原发肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37149, encryptionId=6f553e14927, topicName=原发肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09b838947217, createdName=经常头晕, createdTime=Thu Sep 15 01:08:59 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1885559, encodeId=751d18855598d, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sun May 22 16:08:59 CST 2022, time=2022-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950259, encodeId=d4a9195025971, content=<a href='/topic/show?id=f3b329482a' target=_blank style='color:#2F92EE;'>#ATL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2948, encryptionId=f3b329482a, topicName=ATL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09892, createdName=qidongfanjian, createdTime=Sat Oct 15 14:08:59 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1987876, encodeId=9b4b198e876ae, content=<a href='/topic/show?id=7fa58190354' target=_blank style='color:#2F92EE;'>#肥胖女性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81903, encryptionId=7fa58190354, topicName=肥胖女性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fca128, createdName=licz0423, createdTime=Sun Sep 11 06:08:59 CST 2022, time=2022-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083512, encodeId=9e6f1083512e2, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e0f5588916, createdName=ms4000001117609205, createdTime=Thu Dec 23 11:17:48 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083224, encodeId=5cff108322404, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e495565045, createdName=王江军, createdTime=Wed Dec 22 21:25:25 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1977612, encodeId=25c419e7612aa, content=<a href='/topic/show?id=d9e5130962f' target=_blank style='color:#2F92EE;'>#NST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13096, encryptionId=d9e5130962f, topicName=NST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c5136, createdName=drj2003, createdTime=Mon Nov 07 11:08:59 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1776494, encodeId=da031e76494d1, content=<a href='/topic/show?id=6f553e14927' target=_blank style='color:#2F92EE;'>#原发肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37149, encryptionId=6f553e14927, topicName=原发肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09b838947217, createdName=经常头晕, createdTime=Thu Sep 15 01:08:59 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1885559, encodeId=751d18855598d, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sun May 22 16:08:59 CST 2022, time=2022-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950259, encodeId=d4a9195025971, content=<a href='/topic/show?id=f3b329482a' target=_blank style='color:#2F92EE;'>#ATL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2948, encryptionId=f3b329482a, topicName=ATL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09892, createdName=qidongfanjian, createdTime=Sat Oct 15 14:08:59 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1987876, encodeId=9b4b198e876ae, content=<a href='/topic/show?id=7fa58190354' target=_blank style='color:#2F92EE;'>#肥胖女性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81903, encryptionId=7fa58190354, topicName=肥胖女性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fca128, createdName=licz0423, createdTime=Sun Sep 11 06:08:59 CST 2022, time=2022-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083512, encodeId=9e6f1083512e2, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e0f5588916, createdName=ms4000001117609205, createdTime=Thu Dec 23 11:17:48 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083224, encodeId=5cff108322404, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e495565045, createdName=王江军, createdTime=Wed Dec 22 21:25:25 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2022-05-22 liye789132251
  4. [GetPortalCommentsPageByObjectIdResponse(id=1977612, encodeId=25c419e7612aa, content=<a href='/topic/show?id=d9e5130962f' target=_blank style='color:#2F92EE;'>#NST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13096, encryptionId=d9e5130962f, topicName=NST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c5136, createdName=drj2003, createdTime=Mon Nov 07 11:08:59 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1776494, encodeId=da031e76494d1, content=<a href='/topic/show?id=6f553e14927' target=_blank style='color:#2F92EE;'>#原发肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37149, encryptionId=6f553e14927, topicName=原发肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09b838947217, createdName=经常头晕, createdTime=Thu Sep 15 01:08:59 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1885559, encodeId=751d18855598d, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sun May 22 16:08:59 CST 2022, time=2022-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950259, encodeId=d4a9195025971, content=<a href='/topic/show?id=f3b329482a' target=_blank style='color:#2F92EE;'>#ATL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2948, encryptionId=f3b329482a, topicName=ATL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09892, createdName=qidongfanjian, createdTime=Sat Oct 15 14:08:59 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1987876, encodeId=9b4b198e876ae, content=<a href='/topic/show?id=7fa58190354' target=_blank style='color:#2F92EE;'>#肥胖女性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81903, encryptionId=7fa58190354, topicName=肥胖女性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fca128, createdName=licz0423, createdTime=Sun Sep 11 06:08:59 CST 2022, time=2022-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083512, encodeId=9e6f1083512e2, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e0f5588916, createdName=ms4000001117609205, createdTime=Thu Dec 23 11:17:48 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083224, encodeId=5cff108322404, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e495565045, createdName=王江军, createdTime=Wed Dec 22 21:25:25 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2022-10-15 qidongfanjian
  5. [GetPortalCommentsPageByObjectIdResponse(id=1977612, encodeId=25c419e7612aa, content=<a href='/topic/show?id=d9e5130962f' target=_blank style='color:#2F92EE;'>#NST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13096, encryptionId=d9e5130962f, topicName=NST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c5136, createdName=drj2003, createdTime=Mon Nov 07 11:08:59 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1776494, encodeId=da031e76494d1, content=<a href='/topic/show?id=6f553e14927' target=_blank style='color:#2F92EE;'>#原发肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37149, encryptionId=6f553e14927, topicName=原发肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09b838947217, createdName=经常头晕, createdTime=Thu Sep 15 01:08:59 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1885559, encodeId=751d18855598d, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sun May 22 16:08:59 CST 2022, time=2022-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950259, encodeId=d4a9195025971, content=<a href='/topic/show?id=f3b329482a' target=_blank style='color:#2F92EE;'>#ATL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2948, encryptionId=f3b329482a, topicName=ATL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09892, createdName=qidongfanjian, createdTime=Sat Oct 15 14:08:59 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1987876, encodeId=9b4b198e876ae, content=<a href='/topic/show?id=7fa58190354' target=_blank style='color:#2F92EE;'>#肥胖女性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81903, encryptionId=7fa58190354, topicName=肥胖女性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fca128, createdName=licz0423, createdTime=Sun Sep 11 06:08:59 CST 2022, time=2022-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083512, encodeId=9e6f1083512e2, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e0f5588916, createdName=ms4000001117609205, createdTime=Thu Dec 23 11:17:48 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083224, encodeId=5cff108322404, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e495565045, createdName=王江军, createdTime=Wed Dec 22 21:25:25 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1977612, encodeId=25c419e7612aa, content=<a href='/topic/show?id=d9e5130962f' target=_blank style='color:#2F92EE;'>#NST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13096, encryptionId=d9e5130962f, topicName=NST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c5136, createdName=drj2003, createdTime=Mon Nov 07 11:08:59 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1776494, encodeId=da031e76494d1, content=<a href='/topic/show?id=6f553e14927' target=_blank style='color:#2F92EE;'>#原发肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37149, encryptionId=6f553e14927, topicName=原发肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09b838947217, createdName=经常头晕, createdTime=Thu Sep 15 01:08:59 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1885559, encodeId=751d18855598d, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sun May 22 16:08:59 CST 2022, time=2022-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950259, encodeId=d4a9195025971, content=<a href='/topic/show?id=f3b329482a' target=_blank style='color:#2F92EE;'>#ATL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2948, encryptionId=f3b329482a, topicName=ATL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09892, createdName=qidongfanjian, createdTime=Sat Oct 15 14:08:59 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1987876, encodeId=9b4b198e876ae, content=<a href='/topic/show?id=7fa58190354' target=_blank style='color:#2F92EE;'>#肥胖女性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81903, encryptionId=7fa58190354, topicName=肥胖女性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fca128, createdName=licz0423, createdTime=Sun Sep 11 06:08:59 CST 2022, time=2022-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083512, encodeId=9e6f1083512e2, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e0f5588916, createdName=ms4000001117609205, createdTime=Thu Dec 23 11:17:48 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083224, encodeId=5cff108322404, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e495565045, createdName=王江军, createdTime=Wed Dec 22 21:25:25 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2021-12-23 ms4000001117609205

    学习

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1977612, encodeId=25c419e7612aa, content=<a href='/topic/show?id=d9e5130962f' target=_blank style='color:#2F92EE;'>#NST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13096, encryptionId=d9e5130962f, topicName=NST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c5136, createdName=drj2003, createdTime=Mon Nov 07 11:08:59 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1776494, encodeId=da031e76494d1, content=<a href='/topic/show?id=6f553e14927' target=_blank style='color:#2F92EE;'>#原发肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37149, encryptionId=6f553e14927, topicName=原发肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09b838947217, createdName=经常头晕, createdTime=Thu Sep 15 01:08:59 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1885559, encodeId=751d18855598d, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sun May 22 16:08:59 CST 2022, time=2022-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950259, encodeId=d4a9195025971, content=<a href='/topic/show?id=f3b329482a' target=_blank style='color:#2F92EE;'>#ATL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2948, encryptionId=f3b329482a, topicName=ATL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09892, createdName=qidongfanjian, createdTime=Sat Oct 15 14:08:59 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1987876, encodeId=9b4b198e876ae, content=<a href='/topic/show?id=7fa58190354' target=_blank style='color:#2F92EE;'>#肥胖女性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81903, encryptionId=7fa58190354, topicName=肥胖女性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fca128, createdName=licz0423, createdTime=Sun Sep 11 06:08:59 CST 2022, time=2022-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083512, encodeId=9e6f1083512e2, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e0f5588916, createdName=ms4000001117609205, createdTime=Thu Dec 23 11:17:48 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083224, encodeId=5cff108322404, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e495565045, createdName=王江军, createdTime=Wed Dec 22 21:25:25 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2021-12-22 王江军

    学习了

    0

相关威廉亚洲官网

J Clin Oncol:早期乳腺癌的内分泌治疗中加用帕博西利的效果

内分泌治疗中加用帕博西尼是否可进一步改善激素受体阳性乳腺癌的预后?

这种化疗方案竟增加了这一乳腺癌后乳房重建的并发症风险!

乳房切除术前的新辅助化疗有助于降低乳腺癌的肿瘤负担和病理反应。根据治疗反应,新辅助化疗有可能提供长期生存的预测价值。但关于新辅助化疗如何影响微血管乳房重建后的结果,且目前证据有限。

我不要你觉得,我要我觉得!即使自评,有心理困扰的乳腺癌患者生存时间缩短28年!死亡风险上升45%!

PLoS One.:评估美国乳腺癌患者自我报告的心理痛苦和自我评估的健康状况与生存时间的关系

「依维莫司」新适应症获批,乳腺癌治疗迎来“内分泌+”新时代

作为mTOR抑制剂的代表,依维莫司先后在美国、欧洲、日本等120多个国家获批上市,在全球积累了70000多例使用循证。

J Immunother Cancer:浙大黄建团队提出三阴性乳腺癌肺转移免疫学新机制及其干预策略

乳腺癌是目前发病率最高的恶性肿瘤。随着乳腺癌“在筛早诊早治”推进,精准综合治疗的推广,其生存率已极大提升。尽管如此,三阴性乳腺癌 (TNBC) 由于缺乏相关预测指标和有效针对性的治疗手段。

护士主导的创伤后成长干预对乳腺癌患者有效

护士主导的干预对中国乳腺癌幸存者创伤后成长,缓解焦虑和抑郁有效。